Dr Livia S Carvalho is an early career research fellow that joined the Lions Eye Institute in April 2016 under an ARC Discovery Early Career Research Award. Her interest in vision research dates back to her undergraduate studies in her home country of Brazil where she studies colour vision in South American primates. After finishing a BSc in Biological Sciences from the University of Brasilia, she moved to the UK to pursue an academic research career and completed postgraduate studies at University College London (UCL). This included a Masters’ degree (MSc) in Neuroscience and a Doctorate of Philosophy (PhD) in Genetics, both undertaken at the UCL Institute of Ophthalmology, studying the molecular evolution of colour vision in different species. Following the end of her PhD studies, she successfully transitioned her research interests to the biomedical and translational area of inherited visual degeneration and ocular gene therapy via 7 years of postdoctoral research at the UCL Institute of Ophthalmology (London, UK) and the Schepens Eye Research Institute, Harvard Medical School (Boston, USA).
- Further Key Experience
2013 – 2015: Senior Postdoctoral Fellow, Mass Eye and Ear Infirmary/Schepens Eye Research Institute, Harvard Medical School, Boston, USA
2008 – 2013: Postdoctoral Fellow, University College London, Institute of Ophthalmology, London, UK
2005 – 2008: Research Fellow, University College London, Institute of Ophthalmology, London, UK
2004: Research Assistant, Queen Mary University/UCL Institute of Ophthalmology, London, UK
- Membership of Professional / National / Regional Bodies
Dr Carvalho has been actively involved in the visual science and gene therapy scientific community from the beginning of her career. Memberships include the Association for Research in Vision and Ophthalmology (ARVO, 2005-present), Australasian Gene and Cell Therapy Society (AGCTS, 2016-present) American Society for Gene and Cell Therapy (ASGCT, 2014-present), British Society of Gene and Cell Therapy (BSGCT, 2009-2013) and Genetics Society (2005-2008).
- Research Interests
Dr Carvalho’s current research focus is on creating research platforms in the areas of gene therapy treatments for inherited retinal dystrophies alongside understanding the cellular and molecular mechanisms behind retinal degeneration, photoreceptors cell death mechanisms retinal development during disease.
- Other Professional Achievements
Invited talks include Retina Australia National Congress (October 2015), at the John van Geest Centre for Brain Repair, School of Clinical Medicine, University of Cambridge, UK (July 2015), Annual Fellows Appreciation Day, SERI/MEEI, Boston, USA (June 2015); Annual Seminar Series of the School of Animal Biology, UWA (September 2015) and Trainee Seminar Series SERI, Boston, USA (April 2014). She has also been invited to talk at the University of Melbourne, Dept of Anatomy and Neuroscience (September 2017), at the Children's Medical Research Institute (CMRI) in Sydney (April 2016), at the 2016 Symposium of WA Neuroscience (SWAN – April 2016) and at the Tasmania branch Meeting of the 2016 RANZCO Genetics Meeting (June 2016). CIA Carvalho has also been invited to moderate Plenary sessions during the 2014 ARVO Annual meeting (Novel Drug Development) and at the XVIIth International Symposium on Retinal Degeneration 2016 (Gene Therapy) She was recently nominated by the American Society for Gene and Cell Therapy (ASGCT) for the New Investigator of the Month Award (January 2016) and Awards Spotlight (September 2015). She has also received several travel grant awards from ASGCT (2015 and 2014), NEI (2014), ARVO (2006) and FASEB (2005).